NCT00408239View on ClinicalTrials.gov

Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement

PHASE2CompletedINTERVENTIONAL
Enrollment

367

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Thromboembolism
Interventions
DRUG

YM150

Oral

DRUG

enoxaparin

Sub cutaneous

Trial Locations (19)

833

Kaohsiung City

1008

Manila

1114

Quezon City

14460

Jakarta

16150

Kelantan

50200

Chiang Mai

59100

Kuala Lumpur

Unknown

Chubu Region

Chugoku Region

Kansai Region

Kanto Region

Kyushyu Region

Shikoku Region

Tohoku Region

Singapore

Bangkok

405-760

Incheon

519-809

Jeonnam

110-744

Seoul

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00408239 - Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement | Biotech Hunter | Biotech Hunter